Format

Send to

Choose Destination
Mol Cell. 2015 May 7;58(3):440-52. doi: 10.1016/j.molcel.2015.02.028. Epub 2015 Mar 26.

Interaction with WDR5 promotes target gene recognition and tumorigenesis by MYC.

Author information

1
Department of Cell and Developmental Biology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
2
Department of Biomedical Informatics, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
3
Department of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
4
Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
5
VANTAGE, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
6
Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
7
Department of Biomedical Informatics, Vanderbilt University School of Medicine, Nashville, TN 37232, USA; Department of Cancer Biology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
8
Department of Cell and Developmental Biology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA. Electronic address: william.p.tansey@vanderbilt.edu.

Abstract

MYC is an oncoprotein transcription factor that is overexpressed in the majority of malignancies. The oncogenic potential of MYC stems from its ability to bind regulatory sequences in thousands of target genes, which depends on interaction of MYC with its obligate partner, MAX. Here, we show that broad association of MYC with chromatin also depends on interaction with the WD40-repeat protein WDR5. MYC binds WDR5 via an evolutionarily conserved "MYC box IIIb" motif that engages a shallow, hydrophobic cleft on the surface of WDR5. Structure-guided mutations in MYC that disrupt interaction with WDR5 attenuate binding of MYC at ∼80% of its chromosomal locations and disable its ability to promote induced pluripotent stem cell formation and drive tumorigenesis. Our data reveal WDR5 as a key determinant for MYC recruitment to chromatin and uncover a tractable target for the discovery of anticancer therapies against MYC-driven tumors.

PMID:
25818646
PMCID:
PMC4427524
DOI:
10.1016/j.molcel.2015.02.028
[Indexed for MEDLINE]
Free PMC Article

Publication types, MeSH terms, Substances, Secondary source IDs, Grant support

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center